Chiesi Nordic

  Chiesi is growing, and we were happy to once again gather all new people that have joined us the past year for the Nordic Induction day 2024! This day is an occasion to introduce our new colleagues to where we are heading, our culture and way of working with the focus on understanding where we come from with our Chiesi Nordic story as well as reflecting on how all of us can contribute to a psychological safe environment and practice self-leadership. The Induction Day is an important moment for connecting the dots on how the different functions in the company collaborate throughout research to commercialization. Being a company with a strong heritage and focus on research and innovation, we were proud to welcome the new joiners to the Research & Development site next to the Karolinska Institute with a tour in the lab environment. We leave the Induction Day 2024 with new relationships, insights and a new group of onboarded colleagues to the Nordic team

Today Chiesi Nordic, Angelini Pharma Nordics and the Italian Embassy in Sweden hosted the Italian-Swedish Forum on Research and Innovation at the Embassy of Italy in Stockholm. This event, supported by Business Sweden, exemplified the collaboration between Italy and Sweden in advancing healthcare. The forum brought together diverse stakeholders, including the Italian Medicines Agency, Swedish Medical Products Agency and esteemed researchers from both countries. Key discussions focused on: - Utilizing real-world data and advanced imaging techniques - Enhancing patient care and developing individualized therapies - Exploring potential synergies within Swedish innovation ecosystems   " I look forward to continue and deepen the collaboration with other companies, healthcare professionals and researchers that want to develop solutions for patients with unmet needs as well as finding solutions to a sustainable health care system. I truly believe that we are stronger together", says Olav Fromm, General Manager at Chiesi Nordic. This collaboration between Angelini Pharma Nordics and Chiesi Nordic, highlights our shared commitment to pushing the boundaries of healthcare innovation. The event was moderated by Britta Stenson from Business Sweden, fostering invaluable knowledge exchanges and setting the stage for future collaborations. Together, we are committed to making a substantial impact on patient care. "Angelini Pharma is dedicated to improving patient outcomes through collaboration. This forum allows us to explore the synergies between Italy and Sweden, utilizing real-world data, data imaging and advanced technologies to drive innovation and tackle healthcare challenges together", says Fräs Anna Andersson, General Manager at Angelini Pharma Nordics. Pictured from left to right: Fräs Anna Andersson, General Manager, Angelini Pharma Nordics Karolina Antonov, Lif Britta Stenson, PhD Stenson, Head of Global Industry Network for Life Science, Business Sweden   Michele Pala, Italian ambassador in Sweden Olav Fromm, General Manager, Chiesi Nordic

Water tower illuminated to raise awareness Light Up for Mito is a global campaign hosted by International Mito Patients (IMP) involving illuminating landmarks in green, on Sept. 21st, to raise awareness of mitochondrial diseases (Mito). In Sweden we are happy to also this year see the water tower “Svampen” in Örebro illuminated in beautiful green colour to raise awareness of #mitochondrialdisease, including Leber hereditary optic neuropathy (LHON) We all have Mitochondria – the powerhouse of the cell. It’s responsible for creating energy you need to sustain life and support organ function¹. The parts of your body that need the most energy is most affected by mitochondrial diseases. For example: brain, muscles, eyes¹.   Read more about Light Up For Mito and World Mitochondrial Disease Week here: https://lnkd.in/dyeeKf_U #lightupformito #mitoawarenessweek #worldmitodiseaseweek Referens 1: Conti F et al. Int J Mol Sci. 2023 Nov 25;24(23):16746. doi: 10.3390/ijms242316746. Photographer: Stefan Engström

The ERS congress this year it takes place in Vienna.   The European Respiratory Society (ERS) Congress is an annual event that brings together the world’s respiratory experts to showcase all the latest advances in respiratory medicine and science. Chiesi is of course attending the congress. We know how important it is to keep working to optimize innovative solutions for people who deal with respiratory diseases every day. Photographer: Pernilla Gerell

This week Chiesi Nordic has attended the political week in beautiful Arendal in Norway.   We have met decision makers and patient representatives to discuss what changes that needs to be made to get a sustainable healthcare system. The will is clearly there! We find that both patient advocacy organisations, politicians, authorities and many companies here seem to share the same goal.   We all want a health care system that is sustainable both for the patient and for the planet. Photographer: Ingvild Bjellmo

Join our team! We now searching for an engaged and strategic Value & Access Manager to support the growth of our Rare Disease portfolio in the Nordics. Does this sound interesting? Please find more information on the position and how to apply through the link: https://lnkd.in/dDa3r-F6

Chiesi has participated at the political week at Almedalen in Sweden. During five days we have participated in round-table meetings and listened to inspiring presentations. We have also meet many knowledgeable representatives working towards a better, equal and sustainable healthcare sector. We leave Almedalen with energy and hope.

We were delighted to welcome the Global D&I committee to the Nordics and to take part in the inspiring discussions on how diversity and inclusion is an integral part of our business and future plans. In the Nordics, we are committed to the mission to further build a welcoming and inclusive workplace where everyone is empowered to bring their unique perspectives to the team. Everyone of us is different, everyone of us is Chiesi.

Chiesi is proud the be the first pharma company, together with AstraZeneca, to be part of Järvaveckan outside Stockholm where we in collaboration with the patient organisation HeartLung/Riksförbundet HjärtLung perform lung function tests.   Today at noon we arranged a panel discussion on the topic ”How do we create a society where people affected by COPD get good treatment and mortality decrease?” We thank the panel consisting of: - Karin Fälldin, folkhälsoregionråd Region Stockholm - Anders Åkesson, president Riksförbundet HjärtLung - Emelie Antoni, Country President Nordic & Sweden AstraZeneca - Olav Fromm, General Manager, Chiesi - Nikolaos Lazarinis, specialist in lung medicin and allergology, Karolinska University Hospital

Chiesi at Järvaveckan Chiesi, in collaboration with the Swedish Heart and Lung Association (Riksförbundet HjärtLung) and AstraZeneca, will attend Järvaveckan in Stockholm (May 29th to June 1st) to raise awareness about the lung disease Chronic Obstructive Pulmonary Disease (COPD) and offer free lung function tests to the public. We aim to raise awareness of the disease and highlight the benefits of early detection. #COPD #SpiromeryTesting #JärvaveckanEvent #BreathingMatters #LungHealth